Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

NOVOCURE

Filed by MAYER BROWN LLP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-02 06:26:10 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 19, 2026
Income
$10,000.00
Expenses
Not reported
Registrant
MAYER BROWN LLP
Client
NOVOCURE
Filing UUID
9b65bc5b-e68f-4db7-9ddf-37a4f02fd9b3
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

TRD · Trade (domestic/foreign)

Issues related to Section 232 investigations.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.